Response to: ‘Association of proton pump inhibitors with fracture risk in patients with rheumatoid arthritis’ by Sugiyama | Annals of the Rheumatic Diseases

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Archive
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Article info

Correspondence response

Response to: ‘Association of proton pump inhibitors with fracture risk in patients with rheumatoid arthritis’ by Sugiyama

Free

Authors

Gulsen Ozen University of Nebraska Medical Center, Omaha, Nebraska, USA PubMed articles Google scholar articles
Kaleb Michaud University of Nebraska Medical Center, Omaha, Nebraska, USA FORWARD, The National Databank for Rheumatic Diseases, Wichita, Kansas, USA PubMed articles Google scholar articles

Correspondence to Dr Kaleb Michaud, FORWARD, The National Databank for Rheumatic Diseases, Wichita, KS 67214, USA; kmichaud{at}unmc.edu

Citation

Ozen G, Michaud K

Response to: ‘Association of proton pump inhibitors with fracture risk in patients with rheumatoid arthritis’ by Sugiyama

Annals of the Rheumatic Diseases 2020;79:e111.

Publication history

Received May 23, 2019
Accepted May 25, 2019
First published May 31, 2019.

Online issue publication

August 14, 2020

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.